Advair Diskus Sales Data
| Rank 5 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Advair Diskus U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 5 ( 1) |
$1,247,330 | 2.65% | 5,263 | 0.21% |
| Q3 2013 | 6 | $1,215,177 | -2.11% | 5,252 | -7.01% |
| Q2 2013 | 6 ( 1) |
$1,241,430 | -2.80% | 5,648 | -5.22% |
| Q1 2013 | 5 (1) |
$1,277,171 | 6.00% | 5,959 | 1.81% |
| Q4 2012 | 6 | $1,204,874 | 4.90% | 5,853 | 1.56% |
| Q3 2012 | 6 (2) |
$1,148,611 | 2.10% | 5,763 | 2.47% |
| Q2 2012 | 4 (2) |
$1,124,985 | -1.25% | 5,624 | -3.10% |
| Q1 2012 | 6 (1) |
$1,139,182 | 1.61% | 5,804 | -1.43% |
| Q4 2011 | 7 | $1,121,157 | 5.66% | 5,888 | 3.57% |
| Q3 2011 | 7 (1) |
$1,061,099 | -7.01% | 5,685 | -6.71% |
| Q2 2011 | 6 (1) |
$1,141,117 | -2.39% | 6,094 | -2.93% |
| Q1 2011 | 5 | $1,169,113 | n/a | 6,278 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.